Sandra J. Lee

Also affiliated with Novavax (United States), Dana-Farber Cancer Institute

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 5%percentile

0.541Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Population simulation modeling of disparities in US breast cancer mortality

JNCI Monographs(2023)10.1093/jncimonographs/lgad023

Top 36%

0.541DataRank

Top 36%8 citations

Clyde B. Schechter, Natasha K. Stout, Hui Huang, Sarah Stein, Christina Chapman +9 more

Papers

Driven by 25 papers — median percentile 32. Top paper: “DREAMseq (Doublet, Randomized Evaluation in Advanced Melanoma Sequencing): A phase III trial—ECOG-ACRIN EA6134.”.

DREAMseq (Doublet, Randomized Evaluation in Advanced Melanoma Sequencing): A phase III trial—ECOG-ACRIN EA6134.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.36_suppl.356154

N/A

5.7DataRank · unranked

111 citations

Sandra J. Lee, Bartosz Chmielowski, Antoni Ribas, Ahmad A. Tarhini, Thach‐Giao Truong +9 more

Combination Dabrafenib and Trametinib Versus Combination Nivolumab and Ipilimumab for Patients With Advanced BRAF-Mutant Melanoma: The DREAMseq Trial—ECOG-ACRIN EA6134

Journal of Clinical Oncology(2022)10.1200/jco.22.01763

N/A

5.4DataRank · unranked

446 citations

Sandra J. Lee, Bartosz Chmielowski, Ahmad A. Tarhini, Gary I. Cohen, Thach‐Giao Truong +31 more

Improved prognosis and evidence of enhanced immunogenicity in tumor and circulation of high-risk melanoma patients with unknown primary

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2021-004310

N/A

0.762DataRank · unranked

19 citations

Sandra J. Lee, Aik Choon Tan, Issam M. El Naqa, F. Stephen Hodi, Lisa H. Butterfield +9 more

Enhanced immune activation within the tumor microenvironment and circulation of female high-risk melanoma patients and improved survival with adjuvant CTLA4 blockade compared to males

Journal of Translational Medicine(2022)10.1186/s12967-022-03450-3

N/A

0.614DataRank · unranked

12 citations

Sandra J. Lee, Aik Choon Tan, Issam M. El Naqa, F. Stephen Hodi, Lisa H. Butterfield +10 more

Collaborative Modeling to Compare Different Breast Cancer Screening Strategies

JAMA(2024)10.1001/jama.2023.24766

N/A

0.598DataRank · unranked

53 citations

Christina Chapman, Jinani Jayasekera, Kathryn P. Lowry, Brandy M. Heckman‐Stoddard, John M. Hampton +30 more

Population simulation modeling of disparities in US breast cancer mortality

JNCI Monographs(2023)10.1093/jncimonographs/lgad023

Top 36%

0.541DataRank

Top 36%8 citations

Clyde B. Schechter, Natasha K. Stout, Hui Huang, Sarah Stein, Christina Chapman +9 more

Immune adverse events (irAEs) with adjuvant ipilimumab in melanoma, use of immunosuppressants and association with outcome: ECOG-ACRIN E1609 study analysis

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-002535

N/A

0.520DataRank · unranked

31 citations

Ni Kang, Sandra J. Lee, F. Stephen Hodi, Gary I. Cohen, Omid Hamid +16 more

Granulomatous and Sarcoid-like Immune-Related Adverse Events following CTLA4 and PD1 Blockade Adjuvant Therapy of Melanoma: A Combined Analysis of ECOG-ACRIN E1609 and SWOG S1404 Phase III Trials and a Literature Review

Cancers(2023)10.3390/cancers15092561

N/A

0.396DataRank · unranked

13 citations

Arish Noor, Mahati Paravathaneni, Ibrahim Yassine, Sandra J. Lee, Megan Othus +7 more

Contributions of screening, early-stage treatment, and metastatic treatment to breast cancer mortality reduction by molecular subtype in U.S. women, 2000-2017.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.1008

N/A

0.345DataRank · unranked

9 citations

Liyang Sun, Diego A. Muñoz, Ying Lü, Yisheng Li, Hui Huang +14 more

Granulocyte–Macrophage Colony-Stimulating Factor Influence on Soluble and Membrane-Bound ICOS in Combination with Immune Checkpoint Blockade

Cancer Immunology Research(2023)10.1158/2326-6066.cir-22-0702

N/A

0.241DataRank · unranked

4 citations

Jingjing Li, Yue Zheng, Sandra J. Lee, Jun Zhou, Anita Giobbie‐Hurder +4 more

A phase II study of biomarker-driven early discontinuation of anti–PD-1 therapy in patients with advanced melanoma (PET-Stop): ECOG-ACRIN EA6192.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.tps9591

N/A

0.241DataRank · unranked

4 citations

Sandra J. Lee, Michael B. Atkins, Terence Z. Wong, Jennifer L. Guerriero, Thomas U. Marron +8 more

Early quality of life (QOL) and symptom analysis from the DREAMseq phase III randomized control trial of combination immunotherapy versus targeted therapy in patients (pts) with BRAF-mutant metastatic melanoma (MM) (ECOG-ACRIN EA6134).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.9559

N/A

0.165DataRank · unranked

2 citations

Yue Zheng, Michael B. Atkins, Bartosz Chmielowski, Ahmad A. Tarhini, Thach‐Giao Truong +14 more

Immune adverse events (irAEs) with adjuvant ipilimumab in melanoma, use of hormone replacement and immunosuppressants, and association with outcome: E1609 study analysis.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.5_suppl.60

N/A

0.104DataRank · unranked

1 citations

Sandra J. Lee, Ni Kang, F. Stephen Hodi, Uma N. M. Rao, Gary I. Cohen +5 more

Granulomatous and sarcoid-like immune related adverse events (irAEs) in melanoma patients following CTLA4 blockade adjuvant therapy: An analysis of 1670 high-risk patients.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.9582

N/A

0.104DataRank · unranked

1 citations

Ibrahim Yassine, Sandra J. Lee, Megan Othus, James Moon, John M. Kirkwood +5 more

Patient-reported outcomes among patients with resected high-risk melanoma (AJCC7 IIIB, IIIC, M1a, M1b) randomized to low- or high-dose adjuvant Ipilimumab (ipi) versus high-dose interferon alfa-2b (HDI): Health-related quality of life (HRQL) analysis of ECOG-ACRIN E1609.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.e22078

N/A

0.104DataRank · unranked

1 citations

Yue Zheng, Sandra J. Lee, F. Stephen Hodi, UMA RAO, Gary I. Cohen +4 more

A stochastic model for evaluating the progression of ductal carcinoma in situ breast cancer using Norwegian breast cancer screening program data

Informatics in Medicine Unlocked(2025)10.1016/j.imu.2025.101647

N/A

0DataRank · unranked

0 citations

Harald Weedon‐Fekjær, Bo Zhang, Sandra J. Lee, Xiaoxue Li

Unknown primary tumor high-risk melanoma as a unique patient population with distinct prognosis in the adjuvant setting: An ECOG-ACRIN E1609 study analysis.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.e22090

N/A

0DataRank · unranked

0 citations

Sandra J. Lee, F. Stephen Hodi, Gary I. Cohen, UMA RAO, Vernon K. Sondak +2 more

Impact of the COVID-19 Pandemic on Breast Cancer Mortality in the US: Estimates From Collaborative Simulation Modeling

JNCI Journal of the National Cancer Institute(2021)10.1093/jnci/djab097

N/A

0DataRank · unranked

170 citations

Kathryn P. Lowry, Allison W. Kurian, Jeanne S. Mandelblatt, Mehmet Ali Ergün, Hui Huang +11 more

Impact of disruptions in breast cancer control due to the COVID-19 pandemic on breast cancer mortality in the United States: Estimates from collaborative simulation modeling.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.6562

Top 100%

0DataRank

Top 100%0 citations

Kathryn P. Lowry, Allison W. Kurian, Jeanne S. Mandelblatt, Mehmet Ali Ergün, Hui Huang +10 more

Data from Validation of Melanoma Immune Profile (MIP), a Prognostic Immune Gene Prediction Score for Stage II–III Melanoma

(2023)10.1158/1078-0432.c.6528354

N/A

0DataRank · unranked

0 citations

Douglas K. Marks, Emanuelle M. Rizk, Margaret H. Bogardus, Camille L. Gérard, Luke W. Barker +15 more

Data from Expression of Sorafenib Targets in Melanoma Patients Treated with Carboplatin, Paclitaxel and Sorafenib

(2023)10.1158/1078-0432.c.6517846.v1

N/A

0DataRank · unranked

0 citations

Christopher R. Zito, Sandra J. Lee, Katherine L. Nathanson, Robert L. Camp, David L. Rimm +3 more

Data from Expression of Sorafenib Targets in Melanoma Patients Treated with Carboplatin, Paclitaxel and Sorafenib

(2023)10.1158/1078-0432.c.6517846

N/A

0DataRank · unranked

0 citations

Christopher R. Zito, Sandra J. Lee, Katherine L. Nathanson, Robert L. Camp, David L. Rimm +3 more

A Lasso Cox score consisting of CTLA4+ regulatory T cells (Treg), monocytic myeloid derived suppressor cells (M-MDSC), and CXCR3+ CD8+ T cells: Association with adjuvant ipilimumab (ipi) survival outcomes in patients (pts) with high-risk melanoma.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.e21557

N/A

0DataRank · unranked

0 citations

Timothy I. Shaw, Sandra J. Lee, F. Stephen Hodi, Patrick Hwu, Dung‐Tsa Chen +7 more

Mathematical Modeling to Address Questions in Breast Cancer Screening: An Overview of the Breast Cancer Models of the Cancer Intervention and Surveillance Modeling Network

Journal of Breast Imaging(2025)10.1093/jbi/wbaf003

N/A

0DataRank · unranked

3 citations

Jennifer L. Caswell‐Jin, Harry J. de Koning, Hui Huang, Xuelin Huang, Sandra J. Lee +10 more

Modeling the natural history of ductal carcinoma in situ based on population data

Breast Cancer Research(2020)10.1186/s13058-020-01287-6

N/A

0DataRank · unranked

45 citations

Nicolien T. van Ravesteyn, Xiaoxue Li, Hui Huang, Harald Weedon‐Fekjær, Marc D. Ryser +6 more

Sandra J. Lee

Indexed papers

Top data-sharing exemplar

Papers